Valsartan And Hydrochlorothiazide Tablet, Film Coated
Product Images NDC 71205-042

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Valsartan And Hydrochlorothiazide (NDC 71205-042). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

71205-042-90 (Valsahctz 320 125mg)

71205-042-90 (Valsahctz 320 125mg)
This is a prescription medication with a National Drug Code of 71205-042-90. The medication is Valsartan HCTZ 320mg/12.5mg and comes in a bottle containing 90 tablets. The tablets are oval-shaped and are pink in color. They are film-coated and have 'L238' imprinted on one side. The pills are manufactured by Aurobindo Pharma Limited in India with a product ID of SV004290. The medication should be stored at 25°C (77°F) and kept out of the reach of children. The label also includes a lot number and expiry date, both of which are marked as 00000 and 00/00/00 respectively. The medication has been relabeled by a company called Proficient Rx LP in Thousand Oaks, CA 91320.*
FDA Label Image

Figure 1 (Valsahctz Figur1)

Figure 1 (Valsahctz Figur1)
The text contains a graph labeled Figure 1 showing the probability of achieving a systolic blood pressure below 140 mmHg at week 8. The x-axis displays values between 140 and 180 for the baseline systolic blood pressure in mmHg. The y-axis shows the probability of achieving the target systolic blood pressure. The rest of the text appears to be a table of medication dosages and numerical values of unknown significance.*
FDA Label Image

Figure 2-3-4 (Valsahctz Figure2 3 4)

Figure 2-3-4 (Valsahctz Figure2 3 4)
This text appears to be a chart with figures and labels related to the probability of achieving systolic and diastolic blood pressure targets at week 8 when taking Valsartan and hydrochlorothiazide tablets at varying doses, compared to a placebo. The charts show the baseline SBP and DBP in mmHg, with probabilities ranging from approximately 20 to 100 percent.*
FDA Label Image

Structure (Valsahctz Hctz)

Structure (Valsahctz Hctz)
FDA Label Image

Structure (Valsahctz Valsa)

Structure (Valsahctz Valsa)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.